NTIDs # HVDs (or not?) [Design Issues]

posted by Dr_Dan  – Germany, 2010-06-08 14:24 (5493 d 12:50 ago) – Posting: # 5468
Views: 9,272

Hi Helmut

❝ If we are talking about immunosuppressants, we are talking about a study in patients, right? Steady state too. Likely parallel design – it’s unethical to interrupt treatment by a washout.


If you investigate steady state PK you can do an "active washout" without interrupting treatment.

Regards
Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
19 visitors (0 registered, 19 guests [including 16 identified bots]).
Forum time: 03:14 CEST (Europe/Vienna)

Reach for the stars,
even if you have to stand on a cactus.    Susan Longacre

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5